524564 — Gayatri BioOrganics Income Statement
0.000.00%
- IN₹497.94m
- IN₹865.24m
Annual income statement for Gayatri BioOrganics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 16.7 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0 | 0.798 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.09 | 4.96 | 4.96 | 24.4 | 5.32 |
Operating Profit | -6.09 | -4.96 | -4.96 | -7.68 | -5.32 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.51 | -4.97 | -4.96 | -7.96 | -6.81 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.51 | -4.97 | -4.96 | -10.1 | -6.81 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 845 | -4.97 | -4.96 | -10.1 | -6.81 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 845 | -4.97 | -4.96 | -10.1 | -6.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.07 | -0.063 | -0.063 | -0.128 | -0.086 |